| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2717332 | The American Journal of Medicine | 2008 | 7 Pages |
Abstract
Patients with minimal elevation of serum troponin have smaller infarctions, less aggressive treatment, fewer early complications, and a better early prognosis than patients with higher serum biomarker levels. After discharge, however, their prognosis currently appears no different from that of patients with a “classic” myocardial infarction event.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Philip MD, Dragana MD, Paul MD, Jean-Christophe MD, Giovanni MD, Stephan MD, Osmund MD, AMIS Plus investigators AMIS Plus investigators,